Risk Factors & Outcomes of Immune-Mediated Encephalitis Following Exposure

See also
Status	Clinical Trial	Phase
Completed	`NCT02538094` - tDCS and Cognition in Adults With Multiple Sclerosis or Encephalitis	N/A
Completed	`NCT00381433` - Pharmacokinetic Study of a Single Dose of AVI-4065 in Cerebral Spinal Fluid	Phase 1
Completed	`NCT00031486` - Long Term Treatment of Herpes Simplex Encephalitis (HSE) With Valacyclovir	Phase 3
Completed	`NCT00069303` - Natural History of West Nile Virus Infection	N/A
Completed	`NCT02906631` - Epidemiology and Prognosis of Encephalitis in Intensive Care
Completed	`NCT02367664` - A Clinical Trial for Inactivated Japanese Encephalitis Vaccine in Healthy Chinese Infants	Phase 3
Completed	`NCT00314132` - Safety Study of ChimeriVax™-JE Vaccine to Prevent Japanese Encephalitis.	Phase 3
Terminated	`NCT00927953` - Treatment of West Nile Virus With MGAWN1	Phase 2
Recruiting	`NCT05393492` - Regulating Emotions and Behaviors After Brain Injury	N/A
Terminated	`NCT04361344` - Neurodegeneration Markers and Neurological Course in Severe Covid-19 Infection	N/A
Recruiting	`NCT04460599` - Neurological Features During COVID19
Recruiting	`NCT04372615` - The ExTINGUISH Trial of Inebilizumab in NMDAR Encephalitis	Phase 2
Completed	`NCT02714959` - IL-2 in Refractory Autoimmune Encephalitis	Phase 1/Phase 2
Completed	`NCT01041573` - Safety and Immunogenicity of the Japanese Encephalitis Vaccine IC51 (IXIARO®) in a Pediatric Population	Phase 3
Completed	`NCT01092507` - A Study of Japanese Encephalitis Chimeric Virus Vaccine Compared With SA14-14-2 Vaccine in Infants and Toddlers	Phase 3
Not yet recruiting	`NCT04722328` - Establishment of Prevention and Control System of Central Nervous System Infection
Recruiting	`NCT06067750` - Comparison of Narcotrend and Cerebral Function Analysing Monitor in Intensive Care to Monitor Seizures and Deep Sedation
Not yet recruiting	`NCT06368648` - CoMind Early Feasibility Study
Completed	`NCT02526550` - Immunogenicity of a Live Attenuated Chimeric JE Vaccine (IMOJEV) as a Booster Dose in Thai Children Primed With CD.JEVAX	Phase 4
Completed	`NCT01694524` - Nervous System Infections Among Patients With Febrile Seizure	N/A

NCT number	NCT02856451
Study type	Observational
Source	Bristol-Myers Squibb
Contact
Status	Completed
Phase
Start date	December 9, 2015
Completion date	December 31, 2020

Risk Factors and Outcomes of Immune-Mediated Encephalitis Following Exposure to Nivolumab

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms